Alithea Genomics
Biotech · CH
Swiss biotech scaling high-throughput RNA sequencing kits for drug discovery and toxicology.
Funding history
| Date | Round | Amount |
|---|
| Mar 2026 | Seed Swiss Alithea Genomics closed a CHF 6.9M ($8.9M) seed round to scale its high-throughput RNA sequencing technology. | $8.9M |
Investors
Genku VenturesNovalis BiotechZurcher Kantonalbank
Similar companies in Biotech
Explore funding flow on EquityFlow →